Glucocorticoid
Certain drugs may promote unintentional weight gain in postmenopausal women
Steroid use increases COVID-19 hospitalization risk for patients with rheumatic diseases
Nonsteroidal treatment reduces androgen levels in congenital adrenal hyperplasia
Ruxolitinib effective, safe for glucocorticoid-refractory acute GVHD
Physical therapy superior to glucocorticoid injection for OA pain, functional disability
Endocrinologists warn of increased COVID-19 complication risks with glucocorticoid use
Adults who are prescribed glucocorticoid therapy for common conditions, such as asthma, allergies and arthritis, as well as individuals with adrenal insufficiency, are at high risk for developing serious complications from COVID-19 due to an inability to mount a normal stress response, according to an editorial published in the Journal of Clinical Endocrinology & Metabolism.
Study further characterizes critical illness in COVID-19
Metabolic effects of glucocorticoids reversed with metformin
Adults with inflammatory disease prescribed glucocorticoid therapy experienced an improvement in several metabolic parameters after adding metformin therapy for 12 weeks compared with similar adults assigned placebo, according to findings from a phase 2 study published in The Lancet Diabetes & Endocrinology.
Top recent neuroendocrinology and adrenal news
Early glucocorticoid treatment in congenital adrenal hyperplasia may boost cognitive function
Children and adolescents with congenital adrenal hyperplasia, or CAH, diagnosed early via a neonatal screening program and treated with hydrocortisone had normal psychometric intelligence and executive function compared with population controls, according to findings published in The Journal of Clinical Endocrinology & Metabolism.